↓ Skip to main content

Focal bone lesions in hiv-positive patient treated with tenofovir

Overview of attention for article published in BMC Infectious Diseases, March 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Focal bone lesions in hiv-positive patient treated with tenofovir
Published in
BMC Infectious Diseases, March 2014
DOI 10.1186/1471-2334-14-131
Pubmed ID
Authors

Davide Mangioni, Alessandra Bandera, Antonio Muscatello, Nicola Squillace, Cinzia Crivellaro, Luca Guerra, Cristina Messa, Andrea Gori

Abstract

Tenofovir is a widely used antiviral drug for the treatment of HIV and HBV infection. Although its side effects on renal function and bone metabolism are well known, there are no reports on focal bone lesions caused by this drug. Our case suggests this new, unusual but important scenario.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 23%
Student > Ph. D. Student 2 15%
Other 1 8%
Student > Bachelor 1 8%
Librarian 1 8%
Other 3 23%
Unknown 2 15%
Readers by discipline Count As %
Medicine and Dentistry 9 69%
Immunology and Microbiology 1 8%
Unknown 3 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2014.
All research outputs
#14,776,077
of 22,747,498 outputs
Outputs from BMC Infectious Diseases
#4,059
of 7,664 outputs
Outputs of similar age
#125,816
of 221,372 outputs
Outputs of similar age from BMC Infectious Diseases
#78
of 142 outputs
Altmetric has tracked 22,747,498 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,664 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,372 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 142 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.